UREAphos and METAMORPhos Ligand Kit for Asymmetric Hydrogenation

11,12-Bis[3-methylimidazolium]-9,10-dihydro-9,10-ethanoanthracene bis(iodide), min. 95%

(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(3,5-di-tert-butyl-4-methoxyphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee)

(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 95% (99% ee)

1,2-Bis(diphenylphosphino)ethane monooxide, min. 97%

1,3-Bis(1-adamantyl)-4,5-dihydroimidazolium chloride, min. 97%

1,3-Bis(1-adamantyl)benzimidazolium chloride, min. 97%